Partner Insight: I&I therapies hit new milestones for patients and investors
Cancer, obesity, Alzheimer’s. In recent years, these therapeutic areas have often captured the spotlight given their sizable patient populations and significant medical advances. But inflammation and immunology (I&I) is another…